Plasminogen N-terminal activation peptide modulates the activity of angiostatin-related peptides on endothelial cell proliferation and migration

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 635-640

  Hayashi, Moyuru ^a   Tamura, Yosuke ^a   Dohmae, Naoshi ^b   Kojima, Soichi ^b   Shimonaka, Motoyuki ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b RIKEN   (Japan)

Author keywords

Angiostatin; Kringle domain; Plasminogen; Plasminogen N terminal activation peptide

Indexed keywords

ANGIOSTATIN; PEPTIDE; PLASMINOGEN; PLASMINOGEN AMINO TERMINAL ACTIVATION PEPTIDE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KRINGLE DOMAIN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING;

ANGIOSTATIC PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTHELIAL CELLS; HUMANS; KRINGLES; PLASMINOGEN;

EID: 40849145389     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.050     Document Type: Article

References (24)

1. Forsgren M., Råden B., Israelsson M., Larsson K., and Hedén L.O. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 213 (1987) 254-260
2. Castellino F.J., and McCance S.G. The kringle domains of human plasminogen. Ciba Found. Symp. 212 (1997) 46-60
3. Hoylaerts M., Rijken D.C., Lijnen H.R., and Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257 (1982) 2912-2919
4. Sjöholm I., Wiman B., and Wallén P. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. Eur. J. Biochem. 39 (1973) 471-479
5. Marshall J.M., Brown A.J., and Ponting C.P. Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen. Biochemistry 33 (1994) 3599-3606
6. 1H NMR spectroscopy. J. Biol. Chem. 265 (1990) 3906-3915
7. Lerch P.G., Rickli E.E., Lergier W., and Gillessen D. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. Eur. J. Biochem. 107 (1980) 7-13
8. Markus G., Priore R.L., and Wissler F.C. The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J. Biol. Chem. 254 (1979) 1211-1216
9. Ramesh V., Rajan N., Laursen R.A., and Llinás M. Plasminogen kringle 4 binds the heptapeptide fragment 44-50 of the plasminogen N-terminal peptide. Blood Coagul. Fibrinolysis 6 (1995) 207-218
10. Cockell C.S., Marshall J.M., Dawson K.M., Cederholm-Williams S.A., and Ponting C.P. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem. J. 333 (1998) 99-105
11. An S.S.A., Carreño C., Marti D.N., Schaller J., Albericio F., and Llinás M. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci. 7 (1998) 1960-1969
12. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
13. Sim B.K.L., O'Reilly M.S., Liang H., Fortier A.H., He W., Madsen J.W., Lapcevich R., and Nacy C.A. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57 (1997) 1329-1334
14. MacDonald N.J., Murad A.C., Fogler W.E., Lu Y., and Sim B.K.L. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. Biochem. Biophys. Res. Commun. 264 (1999) 469-477
15. Kwon M., Yoon C.S., Fitzpatrick S., Kassam G., Graham K.S., Young M.K., and Waisman D.M. p22 is a novel plasminogen fragment with antiangiogenic activity. Biochemistry 40 (2001) 13246-13253
16. Cao R., Wu H.L., Veitonmki N., Linden P., Farnebo J., Shi G.Y., and Cao Y. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. USA 96 (1996) 5728-5733
17. Cao Y., Chen A., An S.S.A., Ji R.W., Davidson D., Cao Y., and Llinás M. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272 (1997) 22924-22928
18. Dong Z., Kumar R., Yang X., and Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88 (1997) 801-810
19. Deutsch DG., and Mertz E.T. Plasminogen: purification from human plasma by affinity chromatography. Science 170 (1970) 1095-1096
20. Lewis V.O., Gehrmann M., Weissbach L., Hyman J.E., Rielly A., Jones D.G., Llinás M., and Schaller J. Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides. Eur. J. Biochem. 259 (1999) 618-625
21. Shimonaka M., and Yamaguchi Y. Purification and biological characterization of epitaxin, a fibroblast-derived motility factor for epithelial cells. J. Biol. Chem. 269 (1994) 14284-14289
22. 2-terminal activation peptide as studied by affinity chromatography. Eur. J. Biochem. 50 (1975) 489-494
23. Ji W.R., Barrientos L.G., Llinás M., Gray H., Villarreal X., DeFord M.E., Castellino F.J., Kramer R.A., and Trail P.A. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem. Biophys. Res. Commun. 247 (1998) 414-419
24. Lewis V.O., O'Reilly M.S., Gehrmann M., Llinás M., Schaller J., and Weissbach L. Inhibition of tumor growth by plasminogen-related protein-B. Anticancer Res. 21 (2001) 2287-2291